Brief: Shilpa Medicare Unit VI Receives EIR From USFDA
16/07/2025 06:59
July 16 (Reuters) - Shilpa Medicare Ltd SHME.NS: SHILPA MEDICARE LTD - UNIT VI RECEIVES EIR FROM USFDA SHILPA MEDICARE LTD - RECEIVED EIR WITH VAI CLASSIFICATION FROM USFDA Source text: ID:nBSE7khHSG Further company coverage: SHME.NS ((reuters.briefs@thomsonreuters.com;))
Recent news on Shilpa Medicare
See all newsBrief: Shilpa Medicare Q2 Consol Net Profit INR 791.8 Million
Brief: Shilpa Medicare Says USFDA Conducts Surveillance Inspection At Shilpa Medicare Unit
Brief: Shilpa Medicare Receives Final SEC Approval For Oeris Marketing Authorization
India's Shilpa Medicare gains on approval for OERIS
Brief: Shilpa Medicare Initiates Voluntary Recall Of 27,923 Pemetrexed Injection Vials In Us On July 29, 2026